Healthcare provider profile · identity verified

Ivan Levin, M.D.

Internal Medicine · WINDSOR, VT · NPI 1477848240

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1005	293
Amlodipine Besylate	Amlodipine Besylate	479	131
Lisinopril	Lisinopril	446	119
Levothyroxine Sodium	Levothyroxine Sodium	441	110
Metoprolol Succinate	Metoprolol Succinate	406	113
Losartan Potassium	Losartan Potassium	305	83
Irbesartan	Irbesartan	287	77
Metformin Hcl	Metformin Hcl	277	84
Eliquis	Apixaban	274	66
Omeprazole	Omeprazole	252	75
Hydrochlorothiazide	Hydrochlorothiazide	240	75
Tamsulosin Hcl	Tamsulosin Hcl	229	68
Rosuvastatin Calcium	Rosuvastatin Calcium	192	52
Sertraline Hcl	Sertraline Hcl	189	47
Furosemide	Furosemide	165	48
Gabapentin	Gabapentin	157	53
Simvastatin	Simvastatin	147	38
Alendronate Sodium	Alendronate Sodium	142	37
Pantoprazole Sodium	Pantoprazole Sodium	139	54
Potassium Chloride	Potassium Chloride	134	36
Ozempic	Semaglutide	131	27
Metformin Hcl Er	Metformin Hcl	124	30
Glipizide Er	Glipizide	121	27
Trazodone Hcl	Trazodone Hcl	118	29
Metoprolol Tartrate	Metoprolol Tartrate	114	33
Albuterol Sulfate Hfa	Albuterol Sulfate	113	41
Atenolol	Atenolol	97	25
Allopurinol	Allopurinol	82	23
Clopidogrel	Clopidogrel Bisulfate	82	20
Carvedilol	Carvedilol	75	21
Escitalopram Oxalate	Escitalopram Oxalate	73	18
Torsemide	Torsemide	71	20
Fluticasone Propionate	Fluticasone Propionate	69	28
Jardiance	Empagliflozin	67	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	17
Warfarin Sodium	Warfarin Sodium	59	14
Incruse Ellipta	Umeclidinium Bromide	56	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	14
Fluoxetine Hcl	Fluoxetine Hcl	54	15
Synthroid	Levothyroxine Sodium	53	16
Paroxetine Hcl	Paroxetine Hcl	50	suppressed
Citalopram Hbr	Citalopram Hydrobromide	49	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	48	13
Hydralazine Hcl	Hydralazine Hcl	48	suppressed
Famotidine	Famotidine	47	11
Pravastatin Sodium	Pravastatin Sodium	44	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Buspirone Hcl	Buspirone Hcl	42	suppressed
Enalapril Maleate	Enalapril Maleate	41	suppressed
Trulicity	Dulaglutide	41	suppressed
Finasteride	Finasteride	40	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	39	11
Bupropion Xl	Bupropion Hcl	36	12
Spiriva Handihaler	Tiotropium Bromide	36	suppressed
Spironolactone	Spironolactone	36	11
Glipizide	Glipizide	34	suppressed
Nitroglycerin	Nitroglycerin	34	26
Chlorthalidone	Chlorthalidone	33	suppressed
Prednisone	Prednisone	32	15
Ipratropium Bromide	Ipratropium Bromide	31	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	31	12
Clonazepam	Clonazepam	30	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Risperidone	Risperidone	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	11
Mounjaro	Tirzepatide	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Humalog Kwikpen U-100	Insulin Lispro	27	11
Lovastatin	Lovastatin	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	11
Nifedipine Er	Nifedipine	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Labetalol Hcl	Labetalol Hcl	23	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Nyamyc	Nystatin	22	12
Fenofibrate	Fenofibrate,micronized	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Lorazepam	Lorazepam	20	12
Novolog Flexpen	Insulin Aspart	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Valsartan	Valsartan	20	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Cilostazol	Cilostazol	15	suppressed
Glyburide	Glyburide	15	suppressed
Humulin N	Insulin Nph Human Isophane	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nystatin	Nystatin	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Topiramate Er	Topiramate	13	suppressed
Trimethoprim	Trimethoprim	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Ibuprofen	Ibuprofen	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error